<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=ADCY5</id>
	<title>ADCY5 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=ADCY5"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=ADCY5&amp;action=history"/>
	<updated>2026-06-08T03:39:07Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=ADCY5&amp;diff=5297&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5)  ==Publications==  {{medline-entry |title=...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=ADCY5&amp;diff=5297&amp;oldid=prev"/>
		<updated>2021-05-12T13:38:05Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5)  ==Publications==  {{medline-entry |title=...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5)&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Common genetic variants of the β2-adrenergic receptor affect its translational efficiency and are associated with human longevity.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23020224&lt;br /&gt;
|abstract=β-adrenoceptors are the common pharmacological targets for the treatment of cardiovascular diseases and asthma. Genetic modifications of β-adrenergic system in engineered mice affect their lifespan. Here, we tested whether genes encoding for key components of the β-adrenergic signaling pathway are associated with human longevity. We performed a 10-year follow-up study of the Chinese longitudinal healthy longevity survey. The Han Chinese population in this study consisted of 963 long-lived and 1028 geography-matched young individuals. Sixteen SNPs from [[ADRB1]], [[ADRB2]], [[ADCY5]], [[ADCY6]], and [[MAPK1]] were selected and genotyped. Two SNPs, rs1042718 (C/A) and rs1042719 (G/C), of [[ADRB2]] in linkage disequilibrium (D&amp;#039; = 1.0; r2 = 0.67) were found to be associated with enhanced longevity in men in two geographically isolated populations. Bonferroni-corrected P-values in a combined analysis were 0.00053-0.010. Men with haplotype A-C showed an increased probability to become centenarians (the frequency of A-C in long-lived and young individuals are 0.332 and 0.250, respectively, OR = 1.49, CI 95% = 1.17-1.88, P = 0.0007), in contrast to those with haplotype C-G (the frequency of C-G in long-lived and young individuals are 0.523 and 0.635, respectively, OR = 0.63, CI 95% = 0.51-0.78, P = 0.000018). The permuted P-values were 0.00005 and 0.0009, respectively. [[ADRB2]] encodes the β2-adrenergic receptor; the haplotype A-C markedly reduced its translational efficiency compared with C-G (P = 0.002) in transfected HEK293 cells. Thus, our data indicate that enhanced production of β2-adrenergic receptors caused by genetic variants is inversely associated with human lifespan.&lt;br /&gt;
|mesh-terms=* Adenylyl Cyclases&lt;br /&gt;
* Aged, 80 and over&lt;br /&gt;
* Aging&lt;br /&gt;
* Asian Continental Ancestry Group&lt;br /&gt;
* Case-Control Studies&lt;br /&gt;
* Female&lt;br /&gt;
* Follow-Up Studies&lt;br /&gt;
* Genes, Reporter&lt;br /&gt;
* HEK293 Cells&lt;br /&gt;
* Haplotypes&lt;br /&gt;
* Humans&lt;br /&gt;
* Linkage Disequilibrium&lt;br /&gt;
* Longevity&lt;br /&gt;
* Luciferases, Renilla&lt;br /&gt;
* Male&lt;br /&gt;
* Mitogen-Activated Protein Kinase 1&lt;br /&gt;
* Polymorphism, Single Nucleotide&lt;br /&gt;
* Protein Biosynthesis&lt;br /&gt;
* Receptors, Adrenergic, beta-1&lt;br /&gt;
* Receptors, Adrenergic, beta-2&lt;br /&gt;
* Surveys and Questionnaires&lt;br /&gt;
* Transfection&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633790&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>